RecruitingNot Applicable

Pretreatment of Acute Coronary Syndrome With Dual Antiplatelet Agents

Jordan200 participantsStarted 2025-08-01

Plain-language summary

This is a chart review of data on use of antiplatelet (AP) medications for acute coronary syndrome in the ER. Guidelines recommend giving aspirin in the ER and a second AP agent in the cath lab. What is the outcome when the 2 agents are given n the ER?

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients * Presenting with acute coronary syndrome (ST segment elevation myocardial infarction, non ST segment elevation myocardial infarction, and unstable angina). * Antiplatelet medication (s) prescribed during index admission to hospital. * Willingness of the patient to be called for follow up up to 1 year after index hospitalization. Exclusion Criteria: * Non cardiac chest pain. * No administration of antiplatelet agents during hospitalization. * Refusal of contact for follow up.

What they're measuring

Major bleeding event

Timeframe: From enrollment to the end of the study at 1 year.

Trial details

NCT IDNCT07039149

SponsorJordan Collaborating Cardiology Group

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-08-01

Contact for this trial

Ayman Hammoudeh, MD, FACC

+96265001000 hammoudeh_ayman@yahoo.com

View on ClinicalTrials.gov More Major Bleeding trials